← back to search

Gerd Walz

University of Regensburg · DE
Area of research
Genetics · Molecular Biology
Research interest
Research interests include Medicine, Biology, Internal medicine, Kidney disease, Cell biology, and Autosomal dominant polycystic kidney disease.
h-index
citations
2,303
works
26
NIH funding
primary concept
email

Recent publications

Targeting GLP-1 Signaling Ameliorates Cystogenesis in a Zebrafish Model of Nephronophthisis
International Journal of Molecular Sciences 2025cited by 2position: middledoi
Cyclin-dependent kinase 4 drives cystic kidney disease in the absence of mTORC1 signaling activity
Kidney International 2024cited by 1position: middledoi
Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohort
Bone Research 2023cited by 19position: middledoi
Differential Prognostic Utility of Adiposity Measures in Chronic Kidney Disease
Journal of Renal Nutrition 2023cited by 2position: middledoi
MARVEL domain containing CMTM4 affects CXCR4 trafficking
Molecular Biology of the Cell 2022cited by 3position: middledoi
Urine Metabolite Levels, Adverse Kidney Outcomes, and Mortality in CKD Patients: A Metabolome-wide Association Study
American Journal of Kidney Diseases 2021cited by 40position: middledoi
A molecular mechanism explaining albuminuria in kidney disease
Nature Metabolism 2020cited by 165position: middledoi
Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans
Nature Genetics 2020cited by 147position: middledoi
Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma
Orphanet Journal of Rare Diseases 2019cited by 21position: middledoi
Cilia‐localized <scp>LKB</scp> 1 regulates chemokine signaling, macrophage recruitment, and tissue homeostasis in the kidney
The EMBO Journal 2018cited by 109position: middledoi
A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model
BMC Nephrology 2018cited by 52position: middledoi
CXCL12 and MYC control energy metabolism to support adaptive responses after kidney injury
Nature Communications 2018cited by 51position: lastdoi
FAT1 mutations cause a glomerulotubular nephropathy
Nature Communications 2016cited by 131position: middledoi
A flexible, multilayered protein scaffold maintains the slit in between glomerular podocytes
JCI Insight 2016cited by 106position: middledoi
Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies
Nephrology Dialysis Transplantation 2016cited by 78position: middledoi
The Future of Polycystic Kidney Disease Research—As Seen By the 12 Kaplan Awardees
Journal of the American Society of Nephrology 2015cited by 42position: middledoi
FP064ASSESSING THE LONG TERM OUTCOMES OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) USING THE ADPKD OUTCOMES MODEL: A UK CASE STUDY
Nephrology Dialysis Transplantation 2015cited by 1position: middledoi
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry
Nephrology Dialysis Transplantation 2014cited by 236position: middledoi
Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study
Nephrology Dialysis Transplantation 2014cited by 123position: middledoi
mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress
Proceedings of the National Academy of Sciences 2014cited by 106position: middledoi
RENAL DEVELOPMENT AND CYSTIC DISEASES
Nephrology Dialysis Transplantation 2014cited by 0position: middledoi
Development Of A Model To Predict Disease Progression In Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Value in Health 2014cited by 0position: middledoi
ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3
Nature Genetics 2013cited by 199position: middledoi
aPKCλ/ι and aPKCζ Contribute to Podocyte Differentiation and Glomerular Maturation
Journal of the American Society of Nephrology 2013cited by 40position: middledoi
Exome Capture Reveals ZNF423 and CEP164 Mutations, Linking Renal Ciliopathies to DNA Damage Response Signaling
Cell 2012cited by 391position: middledoi
Vertebrate kidney tubules elongate using a planar cell polarity–dependent, rosette-based mechanism of convergent extension
Nature Genetics 2012cited by 238position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Tobias B. Huber · Universität Hamburg5 papers (2013–2024)Melanie Boerries · University of Freiburg5 papers (2014–2025)Florian Grahammer · University Hospital Heidelberg4 papers (2014–2024) · 3 papers (2018–2025)Richard Sandford · Hospital for Sick Children3 papers (2014–2018) · 3 papers (2014–2018)Albert Ong · University of Sheffield3 papers (2014–2018) · 3 papers (2014–2018)Thomas Benzing · Aarhus University2 papers (2016–2020) · 2 papers (2018–2022) · 2 papers (2014–2024)Wilfried Reichardt · University of Freiburg2 papers (2014–2024)Lukas Sandner · Friedrich-Alexander-Universität Erlangen-Nürnberg2 papers (2014–2024)Christoph Schell · Rockefeller University2 papers (2013–2016) · 2 papers (2016–2019)Hauke Busch · University of Lübeck2 papers (2014–2024) · 2 papers (2013–2020) · 2 papers (2014–2024)Paul Robinson · Center for Cancer Research2 papers (2015–2018)K. O'Reilly · University of California System2 papers (2014–2015)